Macquarie Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,207
| Closed | -$294K | – | 1653 |
|
|
2025
Q1 | $294K | Hold |
1,207
| – | – | ﹤0.01% | 1520 |
|
|
2024
Q4 | $397K | Buy |
1,207
+79
| +7% | +$26.8K | ﹤0.01% | 1466 |
|
|
2024
Q3 | $377K | Sell |
1,128
-1,030
| -48% | -$327K | ﹤0.01% | 1507 |
|
|
2024
Q2 | $589K | Hold |
2,158
| – | – | ﹤0.01% | 1451 |
|
|
2024
Q1 | $746K | Hold |
2,158
| – | – | ﹤0.01% | 1404 |
|
|
2023
Q4 | $697K | Hold |
2,158
| – | – | ﹤0.01% | 1436 |
|
|
2023
Q3 | $774K | Buy |
2,158
+134
| +7% | +$51.7K | ﹤0.01% | 1393 |
|
|
2023
Q2 | $767K | Sell |
2,024
-228
| -10% | -$92.8K | ﹤0.01% | 1400 |
|
|
2023
Q1 | $1.08M | Hold |
2,252
| – | – | ﹤0.01% | 1344 |
|
|
2022
Q4 | $947K | Hold |
2,252
| – | – | ﹤0.01% | 1429 |
|
|
2022
Q3 | $940K | Sell |
2,252
-238
| -10% | -$119K | ﹤0.01% | 1430 |
|
|
2022
Q2 | $1.23M | Buy |
2,490
+373
| +18% | +$194K | ﹤0.01% | 1434 |
|
|
2022
Q1 | $1.19K | Buy |
2,117
+8
| +0.4% | +$4.82K | ﹤0.01% | 1509 |
|
|
2021
Q4 | $1.59M | Sell |
2,109
-665
| -24% | -$498K | ﹤0.01% | 1436 |
|
|
2021
Q3 | $2.07M | Sell |
2,774
-242
| -8% | -$181K | ﹤0.01% | 1377 |
|
|
2021
Q2 | $1.94M | Buy |
3,016
+2,084
| +224% | +$1.27M | ﹤0.01% | 1422 |
|
|
2021
Q1 | $532K | Hold |
932
| – | – | ﹤0.01% | 1520 |
|
|
2020
Q4 | $543K | Sell |
932
-2,859
| -75% | -$1.63M | ﹤0.01% | 1438 |
|
|
2020
Q3 | $1.95M | Buy |
3,791
+467
| +14% | +$237K | ﹤0.01% | 1043 |
|
|
2020
Q2 | $1.5M | Buy |
3,324
+2,724
| +454% | +$1.2M | ﹤0.01% | 1098 |
|
|
2020
Q1 | $210K | Hold |
600
| – | – | ﹤0.01% | 1446 |
|
|
2019
Q4 | $222K | Sell |
600
-700
| -54% | -$247K | ﹤0.01% | 1571 |
|
|
2019
Q3 | $433K | Hold |
1,300
| – | – | ﹤0.01% | 1399 |
|
|
2019
Q2 | $406K | Buy |
1,300
+1,050
| +420% | +$314K | ﹤0.01% | 1399 |
|
|
2019
Q1 | $76K | Sell |
250
-8,935
| -97% | -$2.41M | ﹤0.01% | 1551 |
|
|
2018
Q4 | $2.13M | Sell |
9,185
-6,789
| -43% | -$1.82M | ﹤0.01% | 950 |
|
|
2018
Q3 | $5M | Buy |
15,974
+862
| +6% | +$268K | 0.01% | 792 |
|
|
2018
Q2 | $4.36M | Buy |
+15,112
| New | +$4.17M | 0.01% | 806 |
|
|
2018
Q1 | – | Sell |
-1,170
| Closed | -$279K | – | 2191 |
|
|
2017
Q4 | $279K | Buy |
1,170
+20
| +2% | +$4.85K | ﹤0.01% | 1639 |
|
|
2017
Q3 | $255K | Buy |
+1,150
| New | +$259K | ﹤0.01% | 1673 |
|
Other funds holding BIO
VAM
AI
FPA